Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
#399 most reported symptom for this vaccine
Hypoxia has been reported 52 times in association with Influenza, Seasonal (Flulaval Quadrivalent) vaccination in VAERS. This represents 0.1% of all 52,111 reports for this vaccine.
Among these reports, 4 mentioned death (7.69%) and 42 involved hospitalization (80.8%).
Hypoxia is the #399 most frequently reported symptom for Influenza, Seasonal (Flulaval Quadrivalent) out of 2354 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
Seeing 52 reports of Hypoxia after Influenza, Seasonal (Flulaval Quadrivalent) vaccination may seem alarming, but context is critical.
The 7.69% mortality rate among these reports is elevated, but this reflects the severity of the condition itself rather than vaccine causation.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.